News AI health tech Respiree closes $11.6m Series A Health tech Respiree, developer of AI platforms to manage disease progression, has announced the successful closing of an $11.6m Series A financing.
Home 1000Farmacie Secures $25 Million in Series A Funding The Healthware Ventures portfolio company 1000Farmacie, a leading Italian e-pharmacy marketplace, has announced the successful completion of its second tranche of Series A
News Maxion Therapeutics gets $16m Series A Financing LifeArc Ventures leads $16m Series A of Maxion Therapeutics for antibody development overhaul.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.